Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 65219-029

4 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 65219-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Thi07 0000 01)

Structural Formula (Thi07 0000 01)
Chemical structure of Thiotepa, showing a phosphorus atom bonded to three nitrogen atoms, each connected to an ethyleneimine ring, along with a sulfur double bond attached to the phosphorus.*
FDA Label Image

Fresenius Kabi Logo (Thi07 0000 02)

Fresenius Kabi Logo (Thi07 0000 02)
FDA Label Image

Package Label – Principal Display Panel – 100 mg – Vial Label (Thi07 0000 03)

Package Label – Principal Display Panel – 100 mg – Vial Label (Thi07 0000 03)
Label for Thiotepa for Injection, USP 100 mg/vial, a lyophilized powder for solution intended for intravenous, intracavitary, or intravesical use. The label indicates it is a single dose vial, with instructions to discard unused portion and includes a caution for cytotoxicity. Manufactured for Fresenius Kabi USA, LLC, with manufacturing location in Lake Zurich, IL and product made in India. The label includes barcodes and lot/expiration placeholders.*
FDA Label Image

Package Label – Principal Display Panel – 100 mg – Individual Carton (Thi07 0000 04)

Package Label – Principal Display Panel – 100 mg – Individual Carton (Thi07 0000 04)
Packaging label for Thiotepa for Injection, USP 100 mg/vial by Fresenius Kabi USA, LLC. The lyophilized powder injection is for intravenous, intracavitary, or intravesical use. Label includes storage instructions to keep refrigerated between 2°C to 8°C, usage warning to discard unused portions, and a caution stating it is a cytotoxic agent. Manufactured in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.